Prevalence, pathophysiology, predictive factors, and prognostic significance of anemia in cancer chemotherapy-Reference-Cited by-同舟云学术

Prevalence, pathophysiology, predictive factors, and prognostic significance of anemia in cancer chemotherapy

Published:2002 Issue: Volume: Page:63-100
ISSN:
Container-title:Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology
language:
Short-container-title:

Author:

Nowrousian M. R.

Publisher

Springer Vienna

Link

http://link.springer.com/content/pdf/10.1007/978-3-7091-7658-0_4.pdf

Reference221 articles.

1. Corfu-A Study Group (1995) Phase III randomized study of two fluorouracil combinations with either interferon alfa-2a or leucovorin for advanced colorectal cancer. J Clin Oncol 13: 921–928

2. Abels R, Gordon D, Nelson R, Krantz K, Ageeb M, Goon B, Liebow B (1991) Transfusion practice in advanced cancer patients. Blood 78 (Suppl 1): 474a (Abstract)

3. Abels RI (1992) Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer. Semin Oncol 19 (Suppl 8): 29–35

4. Abels R (1993) Erythropoietin for anaemia in cancer patients. Eur J Cancer 29A (Suppl 2): S2–58

5. Abels R, Larholt K, Nelson R, Young D (1994) Risk of transfusion in small cell lung cancer patients receiving chemotherapy. Blood 84 (Suppl 1): 664a (Abstract)

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Erythropoietin or darbepoetin for patients with cancer;Cochrane Database of Systematic Reviews;2012-12-12

2. Relationship between hemoglobin levels and tumor oxygenation;Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology;2008

3. Erythropoietin or Darbepoetin for patients with cancer;Cochrane Database of Systematic Reviews;2006-07-19

4. Erythropoietin for patients with malignant disease;Cochrane Database of Systematic Reviews;2005-10-19

5. Supportive Therapie mit Zytokinen;Therapiekonzepte Onkologie